Healthcare Global Enterprises Ltd (HCG) — shareholding pattern, promoter holding, financials and share price
About Healthcare Global Enterprises Ltd (HCG)
Healthcare Global Enterprises Ltd operates in the Hospital industry, within the Healthcare sector. It trades on the NSE as HCG and on the BSE under scrip code 539787. Its ISIN is INE075I01017.
Healthcare Global Enterprises Ltd is engaged in setting up and managing hospitals and medical diagnostic services including scientific testing and consultancy services in the pharmaceutical and medical sector. [1]
HealthCare Global Enterprises Limited is India’s largest dedicated oncology platform operating 22–25 comprehensive cancer centres across 19 cities and Kenya, with integrated diagnostics (Triesta), a fertility vertical (Milann) and advanced radiotherapy assets including 38 LINACs and multiple centres of excellence focused on multidisciplinary, tumor-board led cancer care.
Operational momentum in Q3FY26 and 9MFY26 was resilient: 9MF revenue was INR 18,931mn (+15% YoY), volumes rose ~13%, ARPP increased modestly while adjusted EBITDA grew 20% to INR 3,458mn and margins improved to 18.3%, even as reported PAT was impacted by higher depreciation, finance cost and a one-time gratuity adjustment.
Listed peers in Hospital: Dr Agarwals Health Care Ltd, Rainbow Childrens Medicare Ltd, Park Medi World Ltd, Jupiter Life Line Hospitals Ltd, Yatharth Hospital & Trauma Care Services Ltd, Kovai Medical Center & Hospital Ltd.
Valuation & Returns
10 Jul 2026At ₹667.6 a share on 10 Jul 2026, Healthcare Global Enterprises Ltd (HCG) was valued at a price-to-earnings ratio of 437.55x against an industry P/E of 61.73x and a price-to-book of 10.81x on a book value of ₹61.78 per share as of Mar 2025. Solomo computes return on equity of 2.47% and return on capital employed of 7.37% from filed results. Earnings ratios use consolidated results for the twelve months Jun 2025 to Mar 2026.
- P/E
- 437.55x
- Industry P/E
- 61.73x
- P/B
- 10.81x
- EPS (TTM)
- ₹1.53
- Book value / share
- ₹61.78
- ROE
- 2.47%
- ROCE
- 7.37%
- ROA
- 0.64%
- Debt / equity
- 1.99x
- Dividend yield
- 0%
- EBITDA margin
- 17.64%
- 52-week range
- ₹513.4 – ₹799.35
Ratios are computed from filed results and the last recorded price. Not investment advice.
Financial Performance
Mar 2026In the year ended Mar 2026, Healthcare Global Enterprises Ltd (HCG) reported revenue of ₹2,545 crore, net profit of ₹23 crore and earnings per share of ₹0.92. That compares with revenue of ₹2,218 crore and net profit of ₹49 crore in Mar 2025. Figures are consolidated, as filed with the exchanges.
In the quarter ended Mar 2026, revenue was ₹652.33 crore and net profit ₹4.04 crore (consolidated).
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue (₹ cr) | 1,395 | 1,691 | 1,908 | 2,218 | 2,545 |
| Net profit (₹ cr) | 39 | 18 | 41 | 49 | 23 |
| EPS (₹) | 3.65 | 1.99 | 3.27 | 3.01 | 0.92 |
| Measure | 10Y | 5Y | 3Y | 1Y |
|---|---|---|---|---|
| Sales growth | 11.71% | 13.15% | 14.52% | 16.26% |
| Profit growth | - | - | -54.82% | 18.15% |
| Stock price CAGR | 13% | 23% | 27% | 16% |
Ownership Summary
Jun 2026As of Jun 2026, promoters hold 64.21% of Healthcare Global Enterprises Ltd (HCG) (unchanged from the previous quarter), foreign institutional investors (FII) hold 2.74% and domestic institutional investors (DII) hold 19.2%. Promoters have pledged 5.2% of their holding. Market capitalisation was ₹9,967 crore on 10 Jul 2026. Shareholding is filed quarterly with BSE and NSE; Solomo carries every filing back to Mar 2016.
Largest disclosed public shareholders in Jun 2026: NIPPON LIFE INDIA TRUSTEE LTD-A/C NIPPON INDIA ELS 5.88%, AXIS MUTUAL FUND TRUSTEE LIMITED A/C AXIS MUTUAL FUND 3.58%, TATA MUTUAL FUND - TATA ELSS FUND 3.03%, MOTILAL OSWAL S&P BSE HEALTHCARE ETF 2.46%, CLARUS CAPITAL I 1.37%. Only stakes above the 1% disclosure threshold are named in filings.
| Quarter | Promoter | Pledged | FII | DII | Public |
|---|---|---|---|---|---|
| Jun 2026 | 64.21% | 5.2% | 2.74% | 19.2% | 35.79% |
| Mar 2026 | 64.21% | 5.2% | 2.75% | 18.91% | 35.79% |
| Dec 2025 | 63.77% | 5.5% | 3.22% | 18.3% | 36.23% |
| Sep 2025 | 63.78% | 5.5% | 3.59% | 18.36% | 36.22% |
| Jun 2025 | 62.46% | 5.7% | 2.16% | 13.22% | 37.54% |
| Mar 2025 | 71.22% | 5% | 2.45% | 12.47% | 28.78% |
| Dec 2024 | 71.23% | 3.1% | 2.77% | 12.94% | 28.77% |
| Sep 2024 | 71.23% | 3.1% | 4.29% | 11.64% | 28.77% |